The Impact of Different Hormone Therapy Regimens on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tibolone (Primary) ; Estradiol valerate/medroxyprogesterone; Estradiol/medroxyprogesterone
- Indications Menopausal syndrome
- Focus Therapeutic Use
- 02 Jun 2020 Biomarkers information updated
- 13 Nov 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 13 Nov 2013 Last checked against ClinicalTrials.gov record.